Application of AI in preclinical research

online lecture by Florian Krieger (Evotec SE, Hamburg) on ​​March 17, 2026, at 3 p.m.

Moderation: Petra Schultheiß-Reimann

The use of artificial intelligence (AI) has become a central technological and scientific approach in preclinical drug discovery. By analyzing high-dimensional biological and chemical datasets, AI methods enable a significant acceleration and refinement of early development phases. A variety of AI-based approaches contribute to understanding complex molecular relationships and supporting data-driven experimental decision-making. The increasing integration and improvement of multimodal data sources, as well as advances in AI approaches, will further transform preclinical research.

Zoom link for the lecture: https://us06web.zoom.us/j/85944698883?pwd=ekQRb3a3rqavoVkM6ZHR8VnVY946MQ.1

Before the lecture , there will be a five-minute startup introduction. Dr. Marcel Hövels from Sweethoven Biotech ( sweethoven-biotech.com ) will present the development of a sweet dietary fiber as a prebiotic and low-glycemic sugar substitute.